Ark. Goes After J&J For Risperdal Marketing, Costs

The State of Arkansas has filed a lawsuit against Johnson & Johnson and subsidiaries Janssen Pharamceutica Inc. and Janssen LP alleging the companies illegally promoted the antipsychotic drug, Risperdal, to doctors...

Already a subscriber? Click here to view full article